Working with Biopharma to unleash the power of real-world evidence

Aetion helps optimize clinical development by speeding time to market, reducing risk, and increasing trial success. At the same time, we cut costs and generate the robust evidence needed for stronger product labeling.

Our solutions:

• Treatment and disease landscape
• Product label evidence creation
• TPP and trial optimization
• Safety evaluation and monitoring
• Data amplification and augmentation

Aetion supports Biopharma organizations in demonstrating asset value by increasing the productivity of stat and HEOR teams, freeing up time to focus on innovative analysis instead of programming—all while accelerating speed to insights and improving coverage.

Our solutions:

• Payer/HTA value demonstration
• Payer engagement
• Treatment and disease landscape
• Access optimization
• Rare disease value support

Aetion enables organizations to streamline evidence across assets and portfolios by increasing the speed, scalability and quality of real-world evidence (RWE) generation. We ensure transparent and auditable evidence generation while supporting the build out and management of an RWE Center of Excellence.

Our solutions:

• RWE management
• RWD identification and access
• Strategic partnerships
• Synthetic data generation and access
• Data privacy risk assessment and remediation